‘Highly purified and safe vaccine’: Bharat Biotech allays concerns over Covaxin’s quality
Bharat Biotech said that before being released for administering every batch of Covaxin is subjected to over 200 quality control tests and samples are submitted to Government of India’s Central Drugs Laboratory (CDL), and only after clearance are the batches released commercially. Covid-19 vaccine Covaxin manufacturer Bharat Biotech on Thursday issued a statement to allay … Read more